1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Plasma adrenomedullin peptides and precursor levels in pulmonary arterial hypertension disease severity and risk stratification
- Plasma insulin-like growth factor binding protein 1 in pulmonary arterial hypertension
- Plasma biomarkers in pulmonary arterial hypertension diagnosis, treatment response and risk stratification - utilizing Lund Cardio Pulmonary Register
- 2019
- Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se
- Development and Validation of a Questionnaire to Measure Patient's Experiences of Health Care in Pulmonary Arterial Hypertension Outpatient Clinics
- Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension
- 2018
- Plasma l-arginine levels distinguish pulmonary arterial hypertension from left ventricular systolic dysfunction
-
Extended-Release Morphine for Chronic Breathlessness in Pulmonary Arterial Hypertension—A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
Ferreira, Diana H. ; Ekström, Magnus LU
; Sajkov, Dimitar
; Vandersman, Zac
; Eckert, Danny J.
and Currow, David C.
(2018)
In Journal of Pain and Symptom Management
56(4).
p.483-492
Mark
- 2017
- Past and current cause-specific mortality in Eisenmenger syndrome
- Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosis